JP3123137B2 - Method for producing optically active 3-substituted-2-norbornanone - Google Patents

Method for producing optically active 3-substituted-2-norbornanone

Info

Publication number
JP3123137B2
JP3123137B2 JP23109291A JP23109291A JP3123137B2 JP 3123137 B2 JP3123137 B2 JP 3123137B2 JP 23109291 A JP23109291 A JP 23109291A JP 23109291 A JP23109291 A JP 23109291A JP 3123137 B2 JP3123137 B2 JP 3123137B2
Authority
JP
Japan
Prior art keywords
formula
solvent
compound
norbornanone
temperature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP23109291A
Other languages
Japanese (ja)
Other versions
JPH0551345A (en
Inventor
尚之 吉田
光代 杉浦
和利 宮沢
靖幸 小泉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JNC Corp
Original Assignee
Chisso Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chisso Corp filed Critical Chisso Corp
Priority to JP23109291A priority Critical patent/JP3123137B2/en
Priority to US07/931,993 priority patent/US5266728A/en
Priority to EP92307629A priority patent/EP0528694B1/en
Priority to SG1996001566A priority patent/SG54127A1/en
Publication of JPH0551345A publication Critical patent/JPH0551345A/en
Application granted granted Critical
Publication of JP3123137B2 publication Critical patent/JP3123137B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は、様々な生理活性物質の
合成中間体として有用な光学活性3−置換−2−ノルボ
ルナノンの製造法に関するものである。例えば、本化合
物を中間体として、血液凝固阻止剤として有用なトロン
ボキサンA2受容体アンタゴニストを合成することが出
来る(Narisadaら、J.Med.Chem.,
31,1847(1988))。
The present invention relates to a method for producing optically active 3-substituted-2-norbornanones useful as intermediates for synthesizing various physiologically active substances. For example, a thromboxane A2 receptor antagonist useful as a blood coagulation inhibitor can be synthesized using the present compound as an intermediate (Narisada et al., J. Med. Chem.,
31 , 1847 (1988)).

【0002】[0002]

【従来の技術】近年、生理活性物質を光学活性体として
合成することの必要性が高まってきている。これら物質
に複数の光学異性体が存在する場合、各異性体間でその
活性に差異が認められることが多いが、通常強い活性を
示すのは一異性体であり、それ以外の異性体は活性が弱
いか、しばしば望ましくない毒性を示すことが認められ
ている。従って、生理活性物質を特に医薬品として合成
する場合には、望ましい光学異性体を選択的に合成する
ことが、十分な生理活性を発現させるためのみならず、
安全面からも強く望まれる。
2. Description of the Related Art In recent years, there has been an increasing need to synthesize physiologically active substances as optically active substances. When a plurality of optical isomers are present in these substances, differences are often observed in the activities among the isomers.However, one isomer usually shows strong activity, and the other isomer has no activity. Has been found to be weak or often exhibit undesirable toxicity. Therefore, in the case of synthesizing a physiologically active substance particularly as a pharmaceutical, selectively synthesizing a desired optical isomer is not only for expressing sufficient physiological activity,
It is strongly desired from the aspect of safety.

【0003】[0003]

【発明が解決しようとする課題】本発明の光学活性3−
置換−2−ノルボルナノンを効率よく合成するには、光
学活性2−ノルボルナノンを効率よく取得することが必
要である。光学活性2−ノルボルナノンの合成方法に関
しては、(1)ラセミ体のendo−またはexo−2
−ノルボルナノールをジアステレオマー法により光学分
割する方法(Winsteinら、J.Am.Che
m.Soc.,74,1147(1952),Bers
onら、ibid.,83,3986(1961))、
(2)ラセミ体のexo−2−ノルボルナノールまたは
2−ノルボルナノンをウマ肝臓アルコールデヒドロゲナ
ーゼにより不斉酸化または不斉還元する方法(Irwi
nら、J.Am.Chem.Soc.,98,8476
(1976))等が報告されている。しかしながら、
(1)の方法は、光学純度を向上させるために再結晶を
何度も繰り返す必要があり効率的でない。また、(2)
の方法は、試薬が高価なため実用性に乏しく、不斉収率
も低い。
SUMMARY OF THE INVENTION The optical activity 3 of the present invention
In order to efficiently synthesize substituted 2-norbornanone, it is necessary to efficiently obtain optically active 2-norbornanone. Regarding the method of synthesizing optically active 2-norbornanone, (1) racemic endo- or exo-2
-Optical resolution of norbornanol by the diastereomer method (Winstein et al., J. Am. Che
m. Soc. , 74, 1147 (1952), Bers.
on et al., ibid. , 83, 3986 (1961)),
(2) A method for asymmetric oxidation or asymmetric reduction of racemic exo-2-norbornanol or 2-norbornanone with horse liver alcohol dehydrogenase (Irwi
n. Am. Chem. Soc. , 98,8476
(1976)). However,
The method (1) requires repetition of recrystallization many times in order to improve the optical purity, and is not efficient. Also, (2)
In the method (1), the reagent is expensive, so that the method is not practical and the asymmetric yield is low.

【0004】以上のように、いずれの方法も工業的レベ
ルで実用化するには満足のいくものではなかった。以上
のことから、生理活性物質の合成中間体として極めて応
用範囲の広い有用な光学活性3−置換−2−ノルボルナ
ノンの簡便な製造法の開発が強く要望されていた。本発
明者らは、光学活性3−置換−2−ノルボルナノンを効
率よく大量に得るという目的を達成するため鋭意検討し
た結果、前記一般式(II)で表される光学活性3−置
換−2−ノルボルナノンを効率よく大量に得る製造法を
見出し本発明に至った。
As described above, none of these methods has been satisfactory for practical use on an industrial level. From the above, there has been a strong demand for the development of a simple method for producing useful optically active 3-substituted-2-norbornanone, which has a very wide range of applications as a synthetic intermediate for a physiologically active substance. The present inventors have conducted intensive studies to achieve the object of efficiently obtaining a large amount of optically active 3-substituted-2-norbornanone. As a result, the optically active 3-substituted-2-substituted-2-norbornen represented by the general formula (II) was obtained. The present inventors have found a method for efficiently producing norbornanone in large quantities and have led to the present invention.

【0005】[0005]

【課題を解決するための手段】本発明は(1)一般式I The present invention provides (1) a compound represented by the general formula (I):

【0006】[0006]

【化9】 を示し、該基中のR とR は各々独立してC 〜C
のアルキル基またはフェニル基、nは0または1〜3の
整数を示し、*は不斉炭素を示す。)で表される 光学活
性アクリル酸エステルを溶媒中ルイス酸の存在下かつ−
78℃〜室温下でシクロペンタジエンと反応させてディ
ールス・アルダー付加物を得、(2)このディールス・
アルダー付加物を溶媒中塩基性条件下かつ0℃〜50℃
の温度下で加水分解して式(VI)
Embedded image Wherein R 2 and R 3 in the group are each independently C 1 -C 6
An alkyl or phenyl group, n is 0 or 1-3
It shows an integer and * shows asymmetric carbon. Optical activity represented by)
Acrylate in the presence of a Lewis acid in a solvent and
Reaction with cyclopentadiene at 78 ° C to room temperature
(2) this Diels-Alder adduct
The alder adduct is prepared in a solvent under basic conditions at 0 ° C to 50 ° C
Is hydrolyzed at the temperature of formula (VI)

【0007】[0007]

【化10】 (式中、Mは水素またはリチウム、ナトリウムもしくは
カリウムから選ばれる金属を示す。)で表わされる化合
物とし、(3)この式(VI)で表わされる化合物を溶
媒中水素添加触媒の存在下かつ0℃〜50℃の温度下で
接触水素添加して式(III)
Embedded image (Wherein M is hydrogen or lithium, sodium or
Indicates a metal selected from potassium. Compound represented by)
And (3) dissolving the compound represented by the formula (VI).
In the presence of a hydrogenation catalyst in a medium and at a temperature of 0 ° C to 50 ° C
Catalytic hydrogenation gives formula (III)

【0008】[0008]

【化11】 (式中、Mは水素またはリチウム、ナトリウムもしくは
カリウムから選ばれる金属を示す。)で表わされる化合
物を得、(4)この式(III)で表わされる化合物を
過マンガン酸カリウムを用い0℃〜100℃の温度下で
酸化して式(VII)
Embedded image (Wherein M is hydrogen or lithium, sodium or
Indicates a metal selected from potassium. Compound represented by)
And (4) converting the compound represented by the formula (III)
Using potassium permanganate at a temperature of 0 ° C to 100 ° C
Oxidize to formula (VII)

【0009】[0009]

【化12】 で表わされる化合物を得、(5)この式(VII)で表
わされる化合物をビスマス酸ナトリウム−燐酸を用い、
溶媒中室温〜60℃の温度下で酸化的脱炭酸反応に付し
て式(IV)
Embedded image And (5) a compound represented by the formula (VII):
Using sodium bismuthate-phosphoric acid,
Subject to oxidative decarboxylation at room temperature to 60 ° C in a solvent.
Expression (IV)

【0010】[0010]

【化13】 で表わされる化合物を得、(6)この式(IV)で表わされる
化合物を塩基処理してエノール化し、かくして得られる
エノール化物を溶媒中−78℃〜室温下でハロゲン化アル
キル、ハロゲン化アルケニル、またはハロゲン化アラル
キルから選ばれるハロゲン化炭化水素と反応させること
を特徴とする式(II)
Embedded image (6) The compound represented by the formula (IV) is subjected to a base treatment to form an enol, and the thus obtained enolate is subjected to alkyl halide, alkenyl halide, at -78 ° C to room temperature in a solvent . or the formula which comprises reacting a halogenated hydrocarbon selected from aralkyl halides (II)

【0011】[0011]

【化14】 (式中、R はアルキル基、アルケニル基、アルキニル
基、アリール基またはアラルキル基を示す。)で表され
る光学活性3−置換−2−ノルボルナノンの製造法であ
る。また、本発明は、式(VII)
Embedded image (Wherein R 4 represents an alkyl group, an alkenyl group, an alkynyl
Group, an aryl group or an aralkyl group. )
For producing an optically active 3-substituted-2-norbornanone.
You. Further, the present invention provides a compound represented by the formula (VII):

【0012】[0012]

【化15】 で表される化合物を、ビスマス酸ナトリウム−燐酸を用
い溶媒中0℃〜60℃の 温度下酸化的脱炭酸反応に付す
ことを特徴とする式(IV)
Embedded image Using sodium bismuthate-phosphoric acid
Subject to oxidative decarboxylation at 0 ° C to 60 ° C in a solvent
Formula (IV) characterized by the following:

【0013】[0013]

【化16】 で表わされる光学活性2−ノルボルナノンの製造法であ
る。次に本発明について詳細に述べる。本発明の光学活
性3−置換−2−ノルボルナノン(II)は、以下の反
応工程にしたがって製造することが出来る。
Embedded image A method for producing optically active 2-norbornanone represented by
You. Next, the present invention will be described in detail. Optical activity of the present invention
The 3-substituted-2-norbornanone (II) having the following properties
It can be manufactured according to the process.

【0014】[0014]

【化17】 Embedded image

【0015】(式中のRおよびRは上記と同じであ
り、Mは水素またはリチウム、ナトリウムもしくはカリ
ウムから選ばれる金属を示す。)本発明の出発物質であ
る(I)で表される化合物は、(R)−(−)−、また
は(S)−(+)−パントイルラクトン、及び(S)−
(−)−、または(R)−(+)−N−メチル−2−ヒ
ドロキシコハク酸イミドをアクリル酸クロリドと反応さ
せることにより、光学純度よく取得することが出来る
(Pollら、Tetrahedron Lett.,
30,5595(1989).)。
(Wherein R 1 and R 4 are the same as above)
M is hydrogen or lithium, sodium or potassium
Metal selected from the group consisting of ) The compound represented by (I), which is a starting material of the present invention, comprises (R)-(-)-or (S)-(+)-pantoyl lactone, and (S)-
By reacting (-)-or (R)-(+)-N-methyl-2-hydroxysuccinimide with acrylic acid chloride, it can be obtained with high optical purity (Poll et al., Tetrahedron Lett.,
30, 5595 ( 1989 ). ).

【0016】式(V)で表される化合物((+)または
(−)、以下式(VI)、(III)、(VII)、
(IV)および(II)において同じ)は、式(I)で
表される化合物をルイス酸触媒存在下、シクロペンタジ
エンとディールス・アルダー反応させることにより合成
できる。反応に用いられる触媒の例としては四塩化チタ
ン等が挙げられる。反応溶媒としては、塩化メチレン、
クロロホルム、ジクロロエタン等のハロゲン系溶媒、ま
たはこれらとペンタン、ヘキサン、ヘプタン、石油エー
テル等の炭化水素系溶液との混合溶媒を用いることが出
来る。反応温度は−78℃〜室温が適当であり、特に好
ましくは−20℃〜0℃である。
The compound represented by the formula (V) ((+) or
(-), The following formulas (VI), (III), (VII),
(Same in (IV) and (II)) can be synthesized by subjecting the compound represented by formula (I) to a Diels-Alder reaction with cyclopentadiene in the presence of a Lewis acid catalyst. Examples of the catalyst used for the reaction include titanium tetrachloride and the like. As the reaction solvent, methylene chloride,
A halogen-based solvent such as chloroform and dichloroethane, or a mixed solvent of these with a hydrocarbon-based solution such as pentane, hexane, heptane, and petroleum ether can be used. The reaction temperature is suitably from -78 ° C to room temperature, particularly preferably from -20 ° C to 0 ° C.

【0017】式(V)で表される化合物は、塩基性条件
下に加水分解を行うことにより、式(VI)で表される
化合物に容易に変換することが出来る。反応に用いられ
る塩基の例としては、水酸化リチウム、水酸化ナトリウ
ム、水酸化カリウム等が挙げられる。反応溶媒として
は、好ましくは、テトラヒドロフラン等のエーテル系溶
媒が用いられる。反応温度は0〜50℃が適当であり、
特に好ましくは、室温付近である。
The compound of the formula (V) can be easily converted to the compound of the formula (VI) by hydrolysis under basic conditions. Examples of the base used in the reaction include lithium hydroxide, sodium hydroxide, potassium hydroxide and the like. As a reaction solvent, an ether solvent such as tetrahydrofuran is preferably used. The reaction temperature is suitably from 0 to 50 ° C,
Particularly preferably, it is around room temperature.

【0018】式(III)で表される化合物は、式(V
I)で表される化合物を接触水素添加することにより容
易に得ることが出来る。反応に用いられる触媒の例とし
ては、パラジウム−炭素等が挙げられる。反応溶媒とし
てはメタノール、エタノール、ソルミックス等のアルコ
ール系溶媒を用いることが出来る。反応温度は0〜50
℃が適当であり、特に好ましくは室温付近である。
The compound represented by the formula (III) is represented by the formula (V
The compound represented by I) can be easily obtained by catalytic hydrogenation. Examples of the catalyst used for the reaction include palladium-carbon and the like. As a reaction solvent, an alcoholic solvent such as methanol, ethanol, solmix and the like can be used. Reaction temperature is 0-50
C is appropriate, and particularly preferably around room temperature.

【0019】式(VII)で表される化合物は、式(I
II)で表される化合物を酸化することにより得ること
が出来る。反応に用いられる酸化剤の例としては、過マ
ンガン酸カリウムが挙げられる。反応溶媒としてはペン
タン、ヘキサン、ヘプタン、石油エーテル等の炭化水素
系溶媒と水との二相系を用いることが出来る。反応温度
は0〜100℃が適当であり、特に好ましくは室温〜7
0℃である。
The compound represented by the formula (VII) has the formula (I)
It can be obtained by oxidizing the compound represented by II). Examples of the oxidizing agent used for the reaction include potassium permanganate. As a reaction solvent, a two-phase system of a hydrocarbon solvent such as pentane, hexane, heptane, and petroleum ether and water can be used. The reaction temperature is suitably from 0 to 100 ° C, particularly preferably from room temperature to 7 ° C.
0 ° C.

【0020】式(IV)で表される化合物は、式(VI
I)で表される化合物を酸化することにより容易に得る
ことが出来る。反応に用いられる酸化剤の例としては、
ビスマス酸ナトリウム−燐酸、四酢酸鉛、クロム酸−硫
酸等が挙げられる。これらの酸化剤は常法に従って用い
ることが出来るが、例えば、ビスマス酸ナトリウム−燐
酸を酸化剤として用いる場合には、反応溶媒として水を
用いることができ、また反応温度としては室温〜60℃
が好ましい。
The compound represented by the formula (IV) has the formula (VI)
It can be easily obtained by oxidizing the compound represented by I). Examples of the oxidizing agent used in the reaction include:
Examples include sodium bismuthate-phosphoric acid, lead tetraacetate, and chromic acid-sulfuric acid. These oxidizing agents can be used according to a conventional method. For example, when sodium bismuthate-phosphoric acid is used as the oxidizing agent, water can be used as a reaction solvent, and the reaction temperature is from room temperature to 60 ° C.
Is preferred.

【0021】式(II)で表される化合物は、式(I
V)で表される化合物をエノール化した後にハロゲン化
アルキルで捕捉することにより容易に得ることができ
る。エノール化に用いられる塩基の例としては、リチウ
ムジイソプロピルアミド(LDA)、リチウムビス(ト
リメチルシリル)アミド等が挙げられる。またハロゲン
化アルキルの例としては、塩化メチル、臭化メチル、ヨ
ウ化メチル、塩化アリル、臭化アリル、ヨウ化アリル、
塩化ベンジル、臭化ベンジル、ヨウ化ベンジル、塩化ビ
ニル、臭化ビニル、ヨウ化ビニル等が挙げられる。反応
溶媒としてはテトラヒドロフラン等のエーテル系溶媒を
用いることが出来る。反応温度は−78℃〜室温が適当
であり、特に好ましくは−20℃〜0℃である。
The compound represented by the formula (II) has the formula (I)
It can be easily obtained by enolizing the compound represented by V) and then trapping with an alkyl halide. Examples of the base used for enolization include lithium diisopropylamide (LDA), lithium bis (trimethylsilyl) amide and the like. Examples of the alkyl halide include methyl chloride, methyl bromide, methyl iodide, allyl chloride, allyl bromide, allyl iodide,
Benzyl chloride, benzyl bromide, benzyl iodide, vinyl chloride, vinyl bromide, vinyl iodide and the like can be mentioned. An ether solvent such as tetrahydrofuran can be used as the reaction solvent. The reaction temperature is suitably from -78 ° C to room temperature, particularly preferably from -20 ° C to 0 ° C.

【0022】以上の操作により、光学活性3−置換−2
−ノルボルナノンを製造することが出来る。以上のよう
にして得られる光学活性3−置換−2−ノルボルナノン
のうち代表的なものの名称を以下に示す。(+)−3−
メチル−2−ノルボルナノン、(+)−3−エチル−2
−ノルボルナノン、(+)−3−アリル−2−ノルボル
ナノン、(+)−3−ビニル−2−ノルボルナノン、
(+)−3−ベンジル−2−ノルボルナノン、(+)−
3−フェニル−2−ノルボルナノン、
(−)−3−メチル−2−ノル
ボルナノン、(−)−3−エチル−2−ノルボルナノ
ン、(−)−3−アリル−2−ノルボルナノン、(−)
−3−ビニル−2−ノルボルナノン、(−)−3−ベン
ジル−2−ノルボルナノン、(−)−3−フェニル−2
−ノルボルナノン等である。
By the above operation, optically active 3-substituted-2
It is possible to produce norbornanone; The names of typical optically active 3-substituted-2-norbornanones obtained as described above are shown below. (+)-3-
Methyl-2-norbornanone, (+)-3-ethyl-2
-Norbornanone, (+)-3-allyl-2-norbornanone, (+)-3-vinyl-2-norbornanone,
(+)-3-benzyl-2-norbornanone, (+)-
3-phenyl-2-norbornanone,
(-)-3-methyl-2-norbornanone, (-)-3-ethyl-2-norbornanone, (-)-3-allyl-2-norbornanone, (-)
-3-vinyl-2-norbornanone, (-)-3-benzyl-2-norbornanone, (-)-3-phenyl-2
-Norbornanone and the like.

【0023】[0023]

【発明の効果】本発明の製造法は、入手容易な不斉源、
安価な原料および試薬を用いて実施でき、また簡便な操
作によって、光学純度の高い生成物を収率良く得ること
が可能である。即ち、本発明の製造法は、生理活性物質
の合成中間体として極めて応用範囲の広い有用な化合物
である光学活性3−置換−2−ノルボルナノンを効率的
に、しかも大量に得ることができる優れた方法である。
The production method of the present invention provides an easily available asymmetric source,
It can be carried out using inexpensive raw materials and reagents, and it is possible to obtain a product with high optical purity in good yield by a simple operation. That is, the production method of the present invention is an excellent method for efficiently and in large quantities obtaining an optically active 3-substituted-2-norbornanone which is a useful compound having a very wide range of application as a synthetic intermediate of a physiologically active substance. Is the way.

【0024】[0024]

【実施例】以下、実施例によって本発明をより具体的に
説明するが、本発明はこれらの実施例によって制限され
るものではない。 実施例1 (−)−exo−3−アリル−2−ノルボルナノンの製
造 工程1 (R)−(−)−パントイルラクトン46.8g(36
0mmol)、トリエチルアミン54.7g(541m
mol)、塩化メチレン300mlの混合物に、−25
℃にてアクリル酸クロリド41.2g(455mmo
l)を滴下し、−20〜−25℃で5時間撹拌した。氷
冷下、反応混合物に0.5N塩酸500mlを加えて有
機層を分離し、水層を塩化メチレン(150ml×3)
で抽出した。有機層を合わせて飽和重曹水、水、飽和食
塩水(各250ml)で順次洗浄した。無水硫酸マグネ
シウム上で乾燥後、溶媒を濾過、留去し、粗製のアクリ
ル酸エステル64.5gを得た。シリカゲルカラムクロ
マトグラフィー(ヘキサン−酢酸エチル3:1)により
精製し、(R)−ジヒドロ−3−アクリロイルオキシ−
4,4−ジメチル−2(3H)−フラノン61.3g
(333mmol)を得た。収率93%。
The present invention will be described in more detail with reference to the following examples, but the present invention is not limited to these examples. Example 1 Production of (−)-exo-3-allyl-2-norbornanone Step 1 46.8 g of (R)-(−)-pantoyllactone (36
0 mmol), 54.7 g of triethylamine (541 m
mol), 300 ml of methylene chloride, -25
41.2 g of acrylic acid chloride (455 mm
l) was added dropwise, and the mixture was stirred at −20 to −25 ° C. for 5 hours. Under ice-cooling, 500 ml of 0.5N hydrochloric acid was added to the reaction mixture to separate the organic layer, and the aqueous layer was methylene chloride (150 ml × 3).
Extracted. The organic layers were combined and washed sequentially with saturated aqueous sodium hydrogen carbonate, water, and saturated saline (250 ml each). After drying over anhydrous magnesium sulfate, the solvent was filtered and distilled off to obtain 64.5 g of a crude acrylic acid ester. Purification by silica gel column chromatography (hexane-ethyl acetate 3: 1) gave (R) -dihydro-3-acryloyloxy-
61.3 g of 4,4-dimethyl-2 (3H) -furanone
(333 mmol) was obtained. Yield 93%.

【0025】本化合物はH−NMRチャート解析によ
り同定した。H−NMR(CDCl)のデータを下
記に示す。H−NMR:δ 1.1(s,3H),
1.3(s,3H),4.0(s,2H),5.5
(s,1H),5.9−6.7(m,3H)。 工程2 (R)−ジヒドロ−3−アクリロイルオキシ−4,4−
ジメチル−2(3H)−フラノン25.1g(136m
mol)を、塩化メチレン−石油エーテル(7:1)混
合溶媒200mlに溶解し、−15℃にて四塩化チタン
1.6ml(14.6mmol)(石油エーテル10m
lに溶解)を滴下した。−10〜−15℃で30分間撹
拌した後、用時調製したシクロペンタジエン11.9g
(180mmol)を滴下し、3時間同温度で撹拌し
た。炭酸ナトリウム10水塩17.3g(60.4mm
ol)の粉末を少量に分けて加えた後除々に昇温し、室
温で30分間撹拌した。不溶物を濾去し、濾上物を塩化
メチレン(100ml×3)で洗浄した。濾液を洗浄液
と合わせて留去し、粗製のディールス・アルダー付加体
34.0gを得た。ヘキサン−酢酸エチル(5:3)混
合溶媒(125ml)から再結晶し、ディールス・アル
ダー付加体27.5g(110mmol)を得た。収率
81%。
This compound was identified by 1 H-NMR chart analysis. The data of 1 H-NMR (CDCl 3 ) is shown below. 1 H-NMR: δ 1.1 (s, 3H),
1.3 (s, 3H), 4.0 (s, 2H), 5.5
(S, 1H), 5.9-6.7 (m, 3H). Step 2 (R) -dihydro-3-acryloyloxy-4,4-
Dimethyl-2 (3H) -furanone 25.1 g (136 m
mol) was dissolved in 200 ml of a mixed solvent of methylene chloride-petroleum ether (7: 1), and 1.6 ml (14.6 mmol) of titanium tetrachloride (10 m
1) was added dropwise. After stirring at −10 to −15 ° C. for 30 minutes, 11.9 g of cyclopentadiene prepared at the time of use was prepared.
(180 mmol) was added dropwise and stirred at the same temperature for 3 hours. Sodium carbonate decahydrate 17.3 g (60.4 mm
ol) was added in small portions, and the temperature was gradually increased, followed by stirring at room temperature for 30 minutes. The insoluble material was removed by filtration, and the residue was washed with methylene chloride (100 ml × 3). The filtrate was combined with the washing solution and evaporated to obtain 34.0 g of a crude Diels-Alder adduct. Recrystallization from a mixed solvent (125 ml) of hexane-ethyl acetate (5: 3) gave 27.5 g (110 mmol) of a Diels-Alder adduct. Yield 81%.

【0026】本化合物はH−NMRチャート解析によ
り同定した。H−NMR(CDCl)のデータを下
記に示す。H−NMRδ:1.0−2.2(m,4
H),1.1(s,3H),1.2(s,3H),2.
8−3.3(m,3H),4.0(s,2H),5.3
(s,1H),5.8−6.0(m,1H),6.2−
6.4(m,1H)。 工程3 ディールス・アルダー付加体27.5g(110mmo
l)をテトラヒドロフラン−水(5:2)混合溶媒42
0mlに溶解し、氷冷下、水酸化カリウム(85%)3
0.0g(455mmol)(水120mlに溶解)を
加えて室温で24時間撹拌した。テトラヒドロフランを
留去した後、濃塩酸40mlで中和し、ヘキサン−塩化
メチレン(98:2)混合溶媒(150ml×4)で抽
出した。抽出液を無水硫酸マグネシウム上で乾燥した
後、溶媒を濾過、留去して粗製の5−ノルボルネン−2
−カルボン酸15.7gを得た。粗収率100%。
The compound was identified by 1 H-NMR chart analysis. The data of 1 H-NMR (CDCl 3 ) is shown below. 1 H-NMR δ: 1.0-2.2 (m, 4
H), 1.1 (s, 3H), 1.2 (s, 3H), 2.
8-3.3 (m, 3H), 4.0 (s, 2H), 5.3
(S, 1H), 5.8-6.0 (m, 1H), 6.2-
6.4 (m, 1H). Step 3 27.5 g of Diels-Alder adduct (110 mmo
l) in a tetrahydrofuran-water (5: 2) mixed solvent 42
0 ml, and potassium hydroxide (85%) 3
0.0 g (455 mmol) (dissolved in 120 ml of water) was added, and the mixture was stirred at room temperature for 24 hours. After distilling off tetrahydrofuran, the mixture was neutralized with 40 ml of concentrated hydrochloric acid and extracted with a mixed solvent of hexane-methylene chloride (98: 2) (150 ml × 4). After the extract was dried over anhydrous magnesium sulfate, the solvent was filtered and distilled off to give crude 5-norbornene-2.
-15.7 g of carboxylic acid are obtained. Crude yield 100%.

【0027】本化合物は1H-NMRチャート解析により同定
した。1H-NMR(CDCl3) のデータを下記に示す。1 H-NMR: δ 1.1-1.6(m, 3H), 1.7-2.1(m, 1H), 2.7-3.3
(m, 3H), 6.0(dd, 1H), 6.2(dd, 1H), 11.4(brs, 1H) 。 工程4 粗製の5−ノルボルネン−2−カルボン酸 15.7g(110mm
ol) をエタノール300mlに溶解し、5%パラジウム−カ
−ボン末1.55gを加えて水素雰囲気下、室温で24時間撹
拌した。触媒を濾去した後、溶媒を留去し、粗製の2−
ノルボルナンカルボン酸14.5gを得た。粗収率94%。
This compound was identified by 1 H-NMR chart analysis. 1 H-NMR (CDCl 3 ) data is shown below. 1 H-NMR: δ 1.1-1.6 (m, 3H), 1.7-2.1 (m, 1H), 2.7-3.3
(m, 3H), 6.0 (dd, 1H), 6.2 (dd, 1H), 11.4 (brs, 1H). Step 4 15.7 g of crude 5-norbornene-2-carboxylic acid (110 mm
ol) was dissolved in 300 ml of ethanol, 1.55 g of 5% palladium-carbon powder was added, and the mixture was stirred under a hydrogen atmosphere at room temperature for 24 hours. After the catalyst was removed by filtration, the solvent was distilled off, and the crude 2-
14.5 g of norbornanecarboxylic acid were obtained. Crude yield 94%.

【0028】本化合物はH−NMRチャート解析によ
り同定した。H−NMR(CDCl)のデータを下
記に示す。H−NMR:δ1.1−1.9(m,8
H),2.2−2.4(m,1H),2.5−3.0
(m,2H),11.0(brs,1H)。 工程5 水酸化カリウム(85%)24.1g(367mmo
l)、過マンガン酸カリウム18.9g(120mmo
l)を水84mlに溶解し、氷冷下、粗製の2−ノルボ
ルナンカルボン酸8.36g(59.6mmol)の石
油エーテル溶液84mlを滴下した。6時間加熱還流し
た後、室温で18時間撹拌した。氷冷下、反応混合物を
6N硫酸120ml中にゆっくりと加えて酸性にした
後、亜硫酸水素ナトリウム13.0gの水溶液60ml
を加えて室温で1時間撹拌した。エーテル(100ml
×4)で抽出し、抽出液を無水硫酸マグネシウム上で乾
燥した。溶媒を濾過、留去し、粗製の2−ヒドロキシ−
2−ノルボルナンカルボン酸8.34gを得た。粗収率
90%。
The compound was identified by 1 H-NMR chart analysis. The data of 1 H-NMR (CDCl 3 ) is shown below. 1 H-NMR: δ1.1-1.9 (m, 8
H), 2.2-2.4 (m, 1H), 2.5-3.0
(M, 2H), 11.0 (brs, 1H). Step 5 24.1 g (367 mmol) of potassium hydroxide (85%)
l), 18.9 g (120 mmol) of potassium permanganate
1) was dissolved in 84 ml of water, and 84 ml of a petroleum ether solution of 8.36 g (59.6 mmol) of crude 2-norbornanecarboxylic acid was added dropwise under ice cooling. After heating under reflux for 6 hours, the mixture was stirred at room temperature for 18 hours. Under ice-cooling, the reaction mixture was slowly added to 120 ml of 6N sulfuric acid to make it acidic, and then 60 ml of an aqueous solution of 13.0 g of sodium hydrogen sulfite.
Was added and stirred at room temperature for 1 hour. Ether (100ml
× 4), and the extract was dried over anhydrous magnesium sulfate. The solvent was filtered off and evaporated to give crude 2-hydroxy-
8.34 g of 2-norbornanecarboxylic acid were obtained. Crude yield 90%.

【0029】本化合物はH−NMRチャート解析によ
り同定した。H−NMR(CDCl)のデータを下
記に示す。1H−NMR:δ1.0−2.3(m,10
H),7.4(brs,2H)。 工程6 粗製の2−ヒドロキシ−2−ノルボルナンカルボン酸
8.25g(52.8mmol)、ビスマス酸ナトリウ
ム(80%)19.5g(55.7mmol)を、水8
5mlに溶解し、リン酸(85%)18.0g(156
mmol)を滴下して45〜50℃で8時間、室温で1
8時間撹拌した。エーテル(100ml×4)で抽出
し、抽出液を飽和重曹水、水、飽和食塩水(各100m
l)で順次洗浄後、無水硫酸マグネシウム上で乾燥し
た。エーテルを常圧下留去した後、蒸留し(−)−2−
ノルボルナノン3.09g(28.1mmol)を得
た。収率53%。
The compound was identified by 1 H-NMR chart analysis. The data of 1 H-NMR (CDCl 3 ) is shown below. 1H-NMR: δ1.0-2.3 (m, 10
H), 7.4 (brs, 2H). Step 6 8.25 g (52.8 mmol) of crude 2-hydroxy-2-norbornanecarboxylic acid, 19.5 g (55.7 mmol) of sodium bismuthate (80%) were added to water 8
Dissolved in 5 ml, phosphoric acid (85%) 18.0 g (156
mmol) is added dropwise at 45-50 ° C. for 8 hours and at room temperature for 1 hour.
Stir for 8 hours. The mixture was extracted with ether (100 ml × 4), and the extract was washed with saturated aqueous sodium hydrogen carbonate, water, and saturated saline (100 m each).
After sequentially washing in 1), the resultant was dried over anhydrous magnesium sulfate. After ether was distilled off under normal pressure, distillation was carried out to give (−)-2-
3.09 g (28.1 mmol) of norbornanone were obtained. Yield 53%.

【0030】本化合物はH−NMRチャート解析によ
り同定した。H−NMR(CDCl)のデータを下
記に示す。H−NMR:δ1.2−2.3(m,8
H),2.5−2.9(m,2H)。また、物性値は以
下の通りであった。 沸点:174℃ 比旋光度:−28.5゜(cl.55,CHCl) 工程7 リチウムジイソプロピルアミドのテトラヒドロフラン−
ヘキサン2M溶液3.4ml(6.8mmol)に、−
40℃にて(−)−2−ノルボルナノン500mg
(4.54mmol)のテトラヒドロフラン溶液1ml
を滴下し、−20℃で10分間撹拌した。続いて臭化ア
リル540mg(4.46mmol)のテトラヒドロフ
ラン溶液1mlを滴下し、−20℃で30分間撹拌した
後、室温まで昇温し、更に1時間撹拌した。氷冷下、反
応混合物を1N塩酸20ml中に注ぎ、トルエン(50
ml×4)で抽出した。抽出液を飽和重曹水、水、飽和
食塩水(各50ml)で順次洗浄後、無水硫酸マグネシ
ウム上で乾燥した。溶媒を濾過、留去し、粗製の3−ア
リル−2−ノルボルナノン980mgを得た。蒸留によ
り精製し、(−)−exo−3−アリル−2−ノルボル
ナノン550mg(3.66mmol)を得た。収率8
1%。
The compound was identified by 1 H-NMR chart analysis. The data of 1 H-NMR (CDCl 3 ) is shown below. 1 H-NMR: δ1.2-2.3 (m, 8
H), 2.5-2.9 (m, 2H). The physical properties were as follows. Boiling point: 174 ° C. Specific rotation: −28.5 ° (cl. 55, CHCl 3 ) Step 7 Tetrahydrofuran of lithium diisopropylamide
To 3.4 ml (6.8 mmol) of a 2M hexane solution,
At 40 ° C., 500 mg of (−)-2-norbornanone
(4.54 mmol) in 1 ml of tetrahydrofuran solution
Was added dropwise, followed by stirring at −20 ° C. for 10 minutes. Subsequently, 1 ml of a tetrahydrofuran solution of 540 mg (4.46 mmol) of allyl bromide was added dropwise, and the mixture was stirred at −20 ° C. for 30 minutes, heated to room temperature, and further stirred for 1 hour. Under ice cooling, the reaction mixture was poured into 20 ml of 1N hydrochloric acid, and toluene (50 ml) was added.
ml × 4). The extract was washed successively with saturated aqueous sodium hydrogen carbonate, water and saturated saline (50 ml each), and dried over anhydrous magnesium sulfate. The solvent was filtered off and distilled off to obtain 980 mg of crude 3-allyl-2-norbornanone. Purification by distillation yielded 550 mg (3.66 mmol) of (-)-exo-3-allyl-2-norbornanone. Yield 8
1%.

【0031】本化合物はH−NMRチャート解析によ
り同定した。H−NMR(CDCl)のデータを下
記に示す。H−NMR:δ1.2−2.8(m,11
H),4.9−5.3(m,2H),5.6−6.1
(m,1H)。また、物性値は以下の通りであった。 沸点:70〜73℃/3mmHg 比旋光度:−89.1゜(c0.972,CHCl) 実施例2 (+)−exo−3−アリル−2−ノルボルナノンの製
造 工程1 (S)−(−)−N−メチル−2−ヒドロキシコハク酸
イミド69.5g(538mmol)、トリエチルアミ
ン70.8g(700mmol)、塩化メチレン400
mlの混合物に、−25℃にてアクリル酸クロリド6
3.4g(700mmol)を滴下し、−20〜−25
℃で4.5時間撹拌した。氷冷下、反応混合物に1N塩
酸170mlを加えて有機層を分離し、水層を塩化メチ
レン(200ml×3)で抽出した。有機層を合わせて
飽和重曹水、飽和食塩水(各150ml)で順次洗浄し
た。無水硫酸マグネシウム上で乾燥後、溶媒を濾過して
留去し、粗製のアクリル酸エステル96.8gを得た。
シリカゲルカラムクロマトグラフィー(酢酸エチル)に
より精製し、(S)−(−)−N−メチル−3−アクリ
ロイルオキシコハク酸イミド72.2g(394mmo
l)を得た。収率73%。
The compound was identified by 1 H-NMR chart analysis. The data of 1 H-NMR (CDCl 3 ) is shown below. 1 H-NMR: δ1.2-2.8 (m, 11
H), 4.9-5.3 (m, 2H), 5.6-6.1.
(M, 1H). The physical properties were as follows. Boiling point: 70 to 73 ° C./3 mmHg Specific rotation: −89.1 ° (c 0.972, CHCl 3 ) Example 2 Production of (+)-exo-3-allyl-2-norbornanone Step 1 (S)-( -)-N-methyl-2-hydroxysuccinimide 69.5 g (538 mmol), triethylamine 70.8 g (700 mmol), methylene chloride 400
ml of the mixture of acrylic acid chloride 6 at −25 ° C.
3.4 g (700 mmol) was added dropwise and -20 to -25
Stirred at 4.5 ° C. for 4.5 hours. Under ice-cooling, 170 ml of 1N hydrochloric acid was added to the reaction mixture to separate the organic layer, and the aqueous layer was extracted with methylene chloride (200 ml × 3). The organic layers were combined and washed sequentially with saturated aqueous sodium hydrogen carbonate and saturated brine (150 ml each). After drying over anhydrous magnesium sulfate, the solvent was filtered off and distilled off to obtain 96.8 g of a crude acrylic acid ester.
Purified by silica gel column chromatography (ethyl acetate), 72.2 g of (S)-(-)-N-methyl-3-acryloyloxysuccinimide (394 mmol)
1) was obtained. 73% yield.

【0032】本化合物はH−NMRチャート解析によ
り同定した。H−NMR(CDCl)のデータを下
記に示す。H−NMR:δ 2.6−3.5(m,2
H),3.0(s,3H),5.5−5.7(m,1
H),5.8−6.7(m,3H)。 工程2 (S)−(−)−N−メチル−3−アクリロイルオキシ
コハク酸イミド72.2g(394mmol)を塩化メ
チレン−石油エーテル(7:1)混合溶媒580mlに
溶解し、−15℃にて、四塩化チタン4.4ml(4
0.1mmol)(石油エーテル30mlに溶解)を滴
下した。−10〜−15℃で30分間撹拌した後、用時
調製したシクロペンタジエン32.4g(490mmo
l)を滴下し、3.5時間同温度で撹拌した。炭酸ナト
リウム10水塩50.1g(175mmol)の粉末を
少量に分けて加えた後、除々に昇温し、室温で1時間撹
拌した。不溶物を濾去し、濾上物を塩化メチレン(25
0ml×3)で洗浄した。濾液を洗浄液と合わせて留去
し、粗製のディールス・アルダー付加体99.6gを得
た。ヘプタン−酢酸エチル(5:3)混合溶媒(600
ml)から再結晶し、ディールス・アルダー付加体6
7.0g(269mmol)を得た。収率68%。
This compound was identified by 1 H-NMR chart analysis. The data of 1 H-NMR (CDCl 3 ) is shown below. 1 H-NMR: δ 2.6-3.5 (m, 2
H), 3.0 (s, 3H), 5.5-5.7 (m, 1
H), 5.8-6.7 (m, 3H). Step 2 72.2 g (394 mmol) of (S)-(−)-N-methyl-3-acryloyloxysuccinimide was dissolved in 580 ml of a mixed solvent of methylene chloride and petroleum ether (7: 1), and the mixture was dissolved at -15 ° C. , 4.4 ml of titanium tetrachloride (4
0.1 mmol) (dissolved in 30 ml of petroleum ether) was added dropwise. After stirring at -10 to -15 ° C for 30 minutes, 32.4 g (490 mmo) of cyclopentadiene prepared at the time of use was prepared.
l) was added dropwise and stirred at the same temperature for 3.5 hours. After adding powder of 50.1 g (175 mmol) of sodium carbonate decahydrate in a small amount, the temperature was gradually increased, followed by stirring at room temperature for 1 hour. The insoluble material was removed by filtration, and the residue was filtered with methylene chloride (25%
0 ml × 3). The filtrate was combined with the washing solution and evaporated to obtain 99.6 g of a crude Diels-Alder adduct. Heptane-ethyl acetate (5: 3) mixed solvent (600
re-crystallized from Diels-Alder adduct 6
7.0 g (269 mmol) were obtained. Yield 68%.

【0033】本化合物はH−NMRチャート解析によ
り同定した。H−NMR(CDCl)のデータを下
記に示す。H−NMR δ:1.2−2.2(m,4
H),2.4−3.4(m,5H),3.0(s,3
H),5.3−5.5(m,1H),5.8−6.0
(m,1H),6.1−6.3(m,1H)。 工程3 ディールス・アルダー付加体67.0g(269mmo
l)をテトラヒドロフラン−水(5:2)混合溶媒10
40mlに溶解し、氷冷下、水酸化カリウム(85%)
70.5g(1.08mmol)(水300mlに溶
解)を加えて室温で24時間撹拌した。テトラヒドロフ
ランを留去した後、濃塩酸94mlで中和し、ヘキサン
−塩化メチレン(98:2)混合溶媒(200ml×
4)で抽出した。抽出液を無水硫酸マグネシウム上で乾
燥した後、溶媒を濾過、留去して粗製の5−ノルボルネ
ン−2−カルボン酸38.8gを得た。粗収率100
%。
This compound was identified by 1 H-NMR chart analysis. The data of 1 H-NMR (CDCl 3 ) is shown below. 1 H-NMR δ: 1.2-2.2 (m, 4
H), 2.4-3.4 (m, 5H), 3.0 (s, 3
H), 5.3-5.5 (m, 1H), 5.8-6.0.
(M, 1H), 6.1-6.3 (m, 1H). Step 3 Diels-Alder adduct 67.0 g (269 mmo
l) in a tetrahydrofuran-water (5: 2) mixed solvent 10
Dissolve in 40 ml and cool with ice, potassium hydroxide (85%)
70.5 g (1.08 mmol) (dissolved in 300 ml of water) was added, and the mixture was stirred at room temperature for 24 hours. After distilling off tetrahydrofuran, the mixture was neutralized with 94 ml of concentrated hydrochloric acid, and a mixed solvent of hexane-methylene chloride (98: 2) (200 ml ×
Extracted in 4). After the extract was dried over anhydrous magnesium sulfate, the solvent was filtered and distilled off to obtain 38.8 g of crude 5-norbornene-2-carboxylic acid. Crude yield 100
%.

【0034】本化合物は1H-NMRチャート解析により同定
した。1H-NMR(CDCl3) のデータを下記に示す。1 H-NMR: δ 1.1-1.6(m, 3H), 1.7-2.1(m, 1H), 2.7-3.3
(m, 3H), 6.0(dd, 1H), 6.2(dd, 1H), 11.4(brs, 1H) 。 工程4 粗製の5−ノルボルネン−2−カルボン酸38.8g(269mm
ol) を、ソルミックス740ml に溶解し、5%パラジウム
−カ−ボン末1.92gを加えて、水素雰囲気下、室温で1
7.5時間撹拌した。触媒を濾去した後、溶媒を留去し、
粗製の2−ノルボルナンカルボン酸38.0gを得た。粗収
率100 %。
The compound was identified by 1 H-NMR chart analysis. 1 H-NMR (CDCl 3 ) data is shown below. 1 H-NMR: δ 1.1-1.6 (m, 3H), 1.7-2.1 (m, 1H), 2.7-3.3
(m, 3H), 6.0 (dd, 1H), 6.2 (dd, 1H), 11.4 (brs, 1H). Step 4 38.8 g of crude 5-norbornene-2-carboxylic acid (269 mm
The ol), was dissolved in Solmix 740 ml, 5% palladium - Ca - adding carbon powder 1.92 g, under a hydrogen atmosphere at room temperature for 1
Stir for 7.5 hours. After filtering off the catalyst, the solvent was distilled off,
38.0 g of crude 2-norbornanecarboxylic acid were obtained. Crude yield 100%.

【0035】本化合物はH−NMRチャート解析によ
り同定した。H−NMR(CDCl)のデータを下
記に示す。H−NMR:δ1.1−1.9(m,8
H),2.2−2.4(m,1H),2.5−3.0
(m,2H),11.0(brs,1H)。 工程5 水酸化カリウム(85%)107g(1.63mo
l)、過マンガン酸カリウム85.7g(542mmo
l)を水380mlに溶解し、氷冷下粗製の2−ノルボ
ルナンカルボン酸37.9g(271mmol)の石油
エーテル溶液380mlを滴下した。8時間加熱還流し
た後、室温で18時間撹拌した。氷冷下、反応混合物を
6N硫酸544ml中にゆっくりと加えて酸性にした
後、亜硫酸水素ナトリウム62.2gの水溶液272m
lを加えて室温で1時間撹拌した。酢酸エチル(200
ml×4)で抽出し、抽出液を無水硫酸マグネシウム上
で乾燥した。溶媒を濾過、留去し、粗製の2−ヒドロキ
シ−2−ノルボルナンカルボン酸38.5gを得た。粗
収率92%。
The compound was identified by 1 H-NMR chart analysis. The data of 1 H-NMR (CDCl 3 ) is shown below. 1 H-NMR: δ1.1-1.9 (m, 8
H), 2.2-2.4 (m, 1H), 2.5-3.0
(M, 2H), 11.0 (brs, 1H). Step 5 107 g of potassium hydroxide (85%) (1.63 mol)
l), 85.7 g (542 mmol) of potassium permanganate
l) was dissolved in 380 ml of water, and 380 ml of a petroleum ether solution of 37.9 g (271 mmol) of crude 2-norbornanecarboxylic acid was added dropwise under ice cooling. After heating under reflux for 8 hours, the mixture was stirred at room temperature for 18 hours. Under ice-cooling, the reaction mixture was slowly added to 544 ml of 6N sulfuric acid to make it acidic, and then 272 m of an aqueous solution of 62.2 g of sodium bisulfite was added.
was added and the mixture was stirred at room temperature for 1 hour. Ethyl acetate (200
The extract was dried over anhydrous magnesium sulfate. The solvent was filtered and distilled off to obtain 38.5 g of crude 2-hydroxy-2-norbornanecarboxylic acid. Crude yield 92%.

【0036】本化合物はH−NMRチャート解析によ
り同定した。H−NMR(CDCl)のデータを下
記に示す。H−NMR:δ1.0−2.3(m,10
H),7.4(brs,2H)。 工程6 粗製の2−ヒドロキシ−2−ノルボルナンカルボン酸3
8.5g(247mmol)、ビスマス酸ナトリウム
(80%)90.6g(259mmol)を水400m
lに溶解し、リン酸(85%)83.9g(728mm
ol)を滴下して45℃〜50℃で6時間、室温で18
時間撹拌した。酢酸エチル(200ml×4)で抽出
し、抽出液を飽和重曹水、水、飽和食塩水(各200m
l)で順次洗浄後、無水硫酸マグネシウム上で乾燥し
た。酢酸エチルを常圧下留去した後、蒸留し、(+)−
2−ノルボルナノン14.8g(134mmol)を得
た。収率50%。
The compound was identified by 1 H-NMR chart analysis. The data of 1 H-NMR (CDCl 3 ) is shown below. 1 H-NMR: δ1.0-2.3 (m, 10
H), 7.4 (brs, 2H). Step 6 Crude 2-hydroxy-2-norbornanecarboxylic acid 3
8.5 g (247 mmol) and 90.6 g (259 mmol) of sodium bismuthate (80%) in 400 m of water
of phosphoric acid (85%) (728 mm
ol) was added dropwise at 45 ° C to 50 ° C for 6 hours and at room temperature for 18 hours.
Stirred for hours. The mixture was extracted with ethyl acetate (200 ml × 4).
After sequentially washing in 1), the resultant was dried over anhydrous magnesium sulfate. Ethyl acetate was distilled off under normal pressure, and then distilled to obtain (+)-
14.8 g (134 mmol) of 2-norbornanone was obtained. Yield 50%.

【0037】本化合物はH−NMRチャート解析によ
り同定した。H−NMR(CDCl)のデータを下
記に示す。H−NMR:δ1.2−2.3(m,8
H),2.5−2.9(m,2H)。また、物性値は以
下の通りであった。 沸点:174℃ 比旋光度:+29.0゜(cl.51,CHCl) 工程7 リチウムジイソプロピルアミドのテトラヒドロフラン−
ヘキサン2M溶液194ml(388mmol)に、−
40℃にて(+)−2−ノルボルナノン38.9g(3
53mmol)のテトラヒドロフラン溶液50mlを滴
下し、−20℃で10分間撹拌した。続いて臭化アリル
47.0g(388mmol)のテトラヒドロフラン溶
液30mlを滴下し、−20℃で30分間撹拌した後、
室温まで昇温し、更に1時間撹拌した。氷冷下、反応混
合物を2N塩酸300ml中に注ぎ、トルエン(200
ml×4)で抽出した。抽出液を飽和重曹水、水、飽和
食塩水(各200ml)で順次洗浄後、無水硫酸マグネ
シウム上で乾燥した。溶媒を濾過、留去し、粗製の3−
アリル−2−ノルボルナノン77.6gを得た。蒸留に
より精製し、(+)−exo−3−アリル−2−ノルボ
ルナノン42.5g(134mmol)を得た。収率8
0%。
The compound was identified by 1 H-NMR chart analysis. The data of 1 H-NMR (CDCl 3 ) is shown below. 1 H-NMR: δ1.2-2.3 (m, 8
H), 2.5-2.9 (m, 2H). The physical properties were as follows. Boiling point: 174 ° C. Specific rotation: + 29.0 ° (cl. 51, CHCl 3 ) Step 7 Tetrahydrofuran of lithium diisopropylamide
To 194 ml (388 mmol) of a 2M solution of hexane,
At + 40 ° C., 38.9 g of (+)-2-norbornanone (3
50 mmol of a tetrahydrofuran solution (53 mmol) was added dropwise, and the mixture was stirred at −20 ° C. for 10 minutes. Subsequently, 30 ml of a tetrahydrofuran solution of 47.0 g (388 mmol) of allyl bromide was added dropwise, and the mixture was stirred at −20 ° C. for 30 minutes.
The temperature was raised to room temperature, and the mixture was further stirred for 1 hour. Under ice-cooling, the reaction mixture was poured into 300 ml of 2N hydrochloric acid, and toluene (200 ml) was added.
ml × 4). The extract was washed successively with saturated aqueous sodium hydrogen carbonate, water and saturated saline (200 ml each), and then dried over anhydrous magnesium sulfate. The solvent was filtered off and evaporated to give crude 3-
77.6 g of allyl-2-norbornanone was obtained. Purification by distillation gave 42.5 g (134 mmol) of (+)-exo-3-allyl-2-norbornanone. Yield 8
0%.

【0038】本化合物はH−NMRチャート解析によ
り同定した。H−NMR(CDCl)のデータを下
記に示す。H−NMR:δ1.2−2.8(m,11
H),4.9−5.3(m,2H),5.6−6.1
(m,1H)。また、物性値は以下の通りであった。 沸点:71〜72.5℃/3mmHg 比旋光度:+87.3゜(cl.08,CHCl)。
This compound was identified by 1 H-NMR chart analysis. The data of 1 H-NMR (CDCl 3 ) is shown below. 1 H-NMR: δ1.2-2.8 (m, 11
H), 4.9-5.3 (m, 2H), 5.6-6.1.
(M, 1H). The physical properties were as follows. Boiling point: 71-72.5 ° C./3 mmHg Specific rotation: + 87.3 ° (cl.08, CHCl 3 ).

【0039】実施例3 (+)−5−ノルボルネン−2−カルボン酸の製造 工程1 (S)−乳酸エチル59.0g(499mmol)、ト
リエチルアミン55.7g(550mmol)、ジクロ
ロエタン200mlの混合物に、−20℃にてアクリル
酸クロリド49.8g(550mmol)(ジクロロエ
タン100mlに溶解)を滴下し、−20℃で4.5時
間撹拌した。氷冷下、反応混合物に1N塩酸を加えて有
機層を分離し、水層を塩化メチレンで抽出した。有機層
を合わせて飽和重曹水、水で順次洗浄した。無水硫酸マ
グネシウム上で乾燥後、溶媒を濾過、留去し、粗製の
(S)−エチル2−アクリロイルオキシプロピオン酸7
5.0gを得た。
Example 3 Production of (+)-5-norbornene-2-carboxylic acid Step 1 (S) -A mixture of 59.0 g (499 mmol) of ethyl lactate, 55.7 g (550 mmol) of triethylamine and 200 ml of dichloroethane was added with- At 20 ° C., 49.8 g (550 mmol) of acrylic acid chloride (dissolved in 100 ml of dichloroethane) was added dropwise, and the mixture was stirred at −20 ° C. for 4.5 hours. Under ice cooling, 1N hydrochloric acid was added to the reaction mixture, the organic layer was separated, and the aqueous layer was extracted with methylene chloride. The organic layers were combined and washed sequentially with saturated aqueous sodium hydrogen carbonate and water. After drying over anhydrous magnesium sulfate, the solvent was filtered and evaporated, and crude (S) -ethyl 2-acryloyloxypropionic acid 7
5.0 g were obtained.

【0040】工程2 粗製の(S)−エチル2−アクリロイルオキシプロピオ
ン酸67.5g(392mmol)を塩化メチレン15
0mlに溶解し、−20℃にて四塩化チタン5.0ml
(45.6mmol)(ヘキサン30mlに溶解)を滴
下した。−10℃で30分間撹拌した後、用時調製した
シクロペンタジエン31.1g(470mmol)(塩
化メチレン50mlに溶解)を滴下し、2時間同温度で
撹拌した。炭酸ナトリウム10水塩20.0g(69.
9mmol)の粉末を少量に分けて加えた後、徐々に昇
温し、室温で一晩撹拌した。不溶物を濾去し、濾上物を
塩化メチレンで洗浄した。濾液を洗浄液と合わせて飽和
重曹水、水で順次洗浄した。無水硫酸マグネシウム上で
乾燥後、溶媒を濾過、留去し、粗製のディールス・アル
ダー付加体95.0gを定量的に得た。
Step 2 67.5 g (392 mmol) of crude (S) -ethyl 2-acryloyloxypropionic acid was added to methylene chloride 15
0 ml, and titanium tetrachloride 5.0 ml at −20 ° C.
(45.6 mmol) (dissolved in 30 ml of hexane) was added dropwise. After stirring at −10 ° C. for 30 minutes, 31.1 g (470 mmol) of cyclopentadiene prepared for use (dissolved in 50 ml of methylene chloride) was added dropwise, and the mixture was stirred at the same temperature for 2 hours. 20.0 g of sodium carbonate decahydrate (69.
After 9 mmol) of powder was added in small portions, the temperature was gradually raised and the mixture was stirred at room temperature overnight. The insoluble material was removed by filtration, and the residue was washed with methylene chloride. The filtrate was combined with the washing solution and washed sequentially with saturated aqueous sodium hydrogen carbonate and water. After drying over anhydrous magnesium sulfate, the solvent was filtered off and distilled off to obtain 95.0 g of a crude Diels-Alder adduct quantitatively.

【0041】本化合物はH−NMRチャート解析によ
り同定した。H−NMR(CDCl)のデータを下
記に示す。H−NMR:δ1.2−1.5(m,10
H),2.6−3.1(m,3H),4.3(q,2
H),5.1(q,1H),6.0−6.2(m,2
H)。 工程3 ディールス・アルダー付加体95.0g(392mmo
l)をテトラヒドロフラン950mlに溶解し、氷冷
下、水酸化カリウム(85%)103g(1.57mo
l)(水760mlに溶解)を加えて室温で24時間撹
拌した。テトラヒドロフランを留去した後、濃塩酸13
8mlで中和し、ヘキサン−塩化メチレン(98:2)
混合溶媒(200ml×4)で抽出した。抽出液を無水
硫酸マグネシウム上で乾燥した後、溶媒を濾過、留去し
て粗製の5−ノルボルネン−2−カルボン酸45.0g
を得た。粗収率83%。
This compound was identified by 1 H-NMR chart analysis. The data of 1 H-NMR (CDCl 3 ) is shown below. 1 H-NMR: δ1.2-1.5 (m, 10
H), 2.6-3.1 (m, 3H), 4.3 (q, 2
H), 5.1 (q, 1H), 6.0-6.2 (m, 2
H). Step 3 95.0 g of Diels-Alder adduct (392 mmo)
l) was dissolved in 950 ml of tetrahydrofuran, and 103 g (1.57 mol) of potassium hydroxide (85%) was added under ice-cooling.
1) (dissolved in 760 ml of water) was added and the mixture was stirred at room temperature for 24 hours. After distilling off tetrahydrofuran, concentrated hydrochloric acid 13
Neutralized with 8 ml, hexane-methylene chloride (98: 2)
The mixture was extracted with a mixed solvent (200 ml × 4). After the extract was dried over anhydrous magnesium sulfate, the solvent was filtered and distilled off to obtain 45.0 g of crude 5-norbornene-2-carboxylic acid.
I got 83% crude yield.

【0042】本化合物はH−NMRチャート解析によ
り同定した。H−NMR(CDCl)のデータを下
記に示す。H−NMR:δ1.1−1.6(m,3
H),1.7−2.1(m,1H),2.7−3.3
(m,3H),6.0(dd,1H),6.2(dd,
1H),11.4(brs,1H)。
This compound was identified by 1 H-NMR chart analysis. The data of 1 H-NMR (CDCl 3 ) is shown below. 1 H-NMR: δ1.1-1.6 (m, 3
H), 1.7-2.1 (m, 1H), 2.7-3.3.
(M, 3H), 6.0 (dd, 1H), 6.2 (dd,
1H), 11.4 (brs, 1H).

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI C07M 7:00 (58)調査した分野(Int.Cl.7,DB名) C07C 45/29 C07C 49/433 C07C 49/647 C07C 49/653 C07C 49/67 C07B 53/00 C07M 7:00 CA(STN) REGISTRY(STN)──────────────────────────────────────────────────の Continued on the front page (51) Int.Cl. 7 identification code FI C07M 7:00 (58) Investigated field (Int.Cl. 7 , DB name) C07C 45/29 C07C 49/433 C07C 49/647 C07C 49/653 C07C 49/67 C07B 53/00 C07M 7:00 CA (STN) REGISTRY (STN)

Claims (2)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 (1)一般式I 【化1】 を示し、該基中のR2とR3は各々独立してC1〜C6のアルキ
ル基またはフェニル基、nは0または1〜3の整数を示
し、*は不斉炭素を示す。)で表される光学活性アクリ
ル酸エステルを溶媒中ルイス酸の存在下かつ−78℃〜室
温下でシクロペンタジエンと反応させてディールス・ア
ルダー付加物を得、 (2)このディールス・アルダー付加物を溶媒中塩基性条
件下かつ0℃〜50℃の温度下で加水分解して式(VI) 【化2】 (式中、Mは水素またはリチウム、ナトリウムもしくは
カリウムから選ばれる金属を示す。)で表わされる化合
物とし、 (3)この式(VI)で表される化合物を溶媒中水素添加触
媒の存在下0℃〜50℃の温度下で接触水素添加して式(I
II) 【化3】 (式中、Mは水素またはリチウム、ナトリウムもしくは
カリウムから選ばれる金属を示す。)で表わされる化合
物を得、 (4)この式(III)で表わされる化合物を過マンガン酸カリ
ウムを用い0℃〜100℃の温度下で酸化して式(VII) 【化4】 で表わされる化合物を得、 (5)この式(VII)で表わされる化合物をビスマス酸ナトリ
ウム−燐酸を用い、溶媒中室温〜60℃の温度下で酸化的
脱炭酸反応に付して式(IV) 【化5】 で表わされる化合物を得、 (6)この式(IV)で表わされる化合物を塩基処理してエノ
ール化し、かくして得られるエノール化物を溶媒中−78
℃〜室温下でハロゲン化アルキル、ハロゲン化アルケニ
ル、またはハロゲン化アラルキルから選ばれるハロゲン
化炭化水素と反応させることを特徴とする式(II) 【化6】 (式中、R4はアルキル基、アルケニル基またはアラルキ
ル基を示す。)で表される光学活性3−置換−2−ノル
ボルナノンの製造法。
(1) General formula I Wherein R 2 and R 3 each independently represent a C 1 to C 6 alkyl group or phenyl group, n represents 0 or an integer of 1 to 3, and * represents an asymmetric carbon. ) Is reacted with cyclopentadiene in a solvent at −78 ° C. to room temperature in the presence of a Lewis acid to obtain a Diels-Alder adduct. (2) The Diels-Alder adduct is obtained. Hydrolysis under basic conditions in a solvent and at a temperature of 0 ° C. to 50 ° C. yields the compound of formula (VI) (Wherein, M represents hydrogen or a metal selected from lithium, sodium or potassium). (3) The compound represented by the formula (VI) is dissolved in a solvent in the presence of a hydrogenation catalyst. Catalytic hydrogenation at a temperature of 50 ° C to 50 ° C, the formula (I
II) (Wherein M represents hydrogen or a metal selected from lithium, sodium or potassium). (4) The compound represented by the formula (III) is treated with potassium permanganate at 0 ° C. Oxidation at a temperature of 100 ° C. gives formula (VII) (5) The compound represented by the formula (VII) is subjected to an oxidative decarboxylation reaction using sodium bismuthate-phosphoric acid in a solvent at room temperature to 60 ° C. to obtain a compound represented by the formula (IV) ) (6) The compound represented by formula (IV) is treated with a base to form an enol, and the enol compound thus obtained is -78 in a solvent.
Reacting with a halogenated hydrocarbon selected from alkyl halides, alkenyl halides, or aralkyl halides at a temperature of from 0 ° C. to room temperature; (Wherein, R 4 is an alkyl group, an alkenyl Motoma other represents an aralkyl group.) Process for producing an optically active 3-substituted-2-norbornanone represented by.
【請求項2】 式(VII) 【化7】 で表される化合物を、ビスマス酸ナトリウム−燐酸を用
い溶媒中0℃〜60℃の温度下酸化的脱炭酸反応に付すこ
とを特徴とする式(IV) 【化8】 で表わされる光学活性2−ノルボルナノンの製造法。
2. A compound of the formula (VII) Wherein the compound of formula (IV) is subjected to an oxidative decarboxylation reaction in a solvent at a temperature of 0 ° C. to 60 ° C. using sodium bismuthate-phosphoric acid. A method for producing optically active 2-norbornanone represented by the formula:
JP23109291A 1991-08-20 1991-08-20 Method for producing optically active 3-substituted-2-norbornanone Expired - Fee Related JP3123137B2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP23109291A JP3123137B2 (en) 1991-08-20 1991-08-20 Method for producing optically active 3-substituted-2-norbornanone
US07/931,993 US5266728A (en) 1991-08-20 1992-08-19 Method for producing optically active 3-substituted-2-norbornanones and their intermediates
EP92307629A EP0528694B1 (en) 1991-08-20 1992-08-20 Method for producing optically active 3-substituted-2-norbornanones and their intermediates
SG1996001566A SG54127A1 (en) 1991-08-20 1992-08-20 Method for producing optically active 3-substituted-2-norbornanones and their immediates

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23109291A JP3123137B2 (en) 1991-08-20 1991-08-20 Method for producing optically active 3-substituted-2-norbornanone

Publications (2)

Publication Number Publication Date
JPH0551345A JPH0551345A (en) 1993-03-02
JP3123137B2 true JP3123137B2 (en) 2001-01-09

Family

ID=16918167

Family Applications (1)

Application Number Title Priority Date Filing Date
JP23109291A Expired - Fee Related JP3123137B2 (en) 1991-08-20 1991-08-20 Method for producing optically active 3-substituted-2-norbornanone

Country Status (1)

Country Link
JP (1) JP3123137B2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6360260B1 (en) 1996-11-12 2002-03-19 International Business Machines Corporation Discovery features for SNMP managed devices
US6545982B1 (en) 1993-07-19 2003-04-08 Marconi Communications Technology, Inc. Communication apparatus and methods
WO2019065708A1 (en) 2017-09-26 2019-04-04 株式会社女性医療研究所 Assistive device for supporting pelvic floor muscle

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4511093B2 (en) * 2001-12-20 2010-07-28 本州化学工業株式会社 Method for producing alicyclic monoolefin carboxylic acid
JP4546798B2 (en) * 2004-09-30 2010-09-15 本州化学工業株式会社 Process for producing exo-type crosslinked alicyclic monoolefin carboxylic acid
CN1308305C (en) * 2005-04-21 2007-04-04 浙江工业大学 Method for synthesizing imide base substituted endo compound
WO2010071122A1 (en) * 2008-12-19 2010-06-24 第一三共株式会社 Cyclohexene derivative manufacturing method

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6545982B1 (en) 1993-07-19 2003-04-08 Marconi Communications Technology, Inc. Communication apparatus and methods
US6360260B1 (en) 1996-11-12 2002-03-19 International Business Machines Corporation Discovery features for SNMP managed devices
WO2019065708A1 (en) 2017-09-26 2019-04-04 株式会社女性医療研究所 Assistive device for supporting pelvic floor muscle

Also Published As

Publication number Publication date
JPH0551345A (en) 1993-03-02

Similar Documents

Publication Publication Date Title
JP3171931B2 (en) (R)-(-)-4-cyano-3-hydroxybutyric acid t-butyl ester and method for producing the same
JP3123137B2 (en) Method for producing optically active 3-substituted-2-norbornanone
EP0640579B1 (en) Process for producing optically active 2-norbornanone
JPH07116175B2 (en) Intermediates for the synthesis of carboxylic acids
JPH0417937B2 (en)
EP0528694B1 (en) Method for producing optically active 3-substituted-2-norbornanones and their intermediates
JP3118939B2 (en) Method for producing optically active 2-hydroxy-2-norbornanecarboxylic acid
JP2864491B2 (en) Method for producing optically active 2-norbornanone
JPH0525078A (en) Production of substituted acetoaldehyde
JP2824159B2 (en) (S)-(-)-α-Damascon production method
JP3497876B2 (en) Method for producing 9Z-β-ionylidene acetate and intermediate compound useful for the method
JPH04226936A (en) Process for producing 2,2-dimethyl-5-(2,5-dimethylphenoxy)- pentanoic acid, intermediate for its production and process for producing said intermediate
JP2542843B2 (en) Novel norbornane derivative and method for producing the same
EP0210171A1 (en) Imined synthesis compounds containing a quaternary chiral carbon atom, preparation and utilization thereof
JP4958513B2 (en) Method for producing sedanenolide
JPS6231700B2 (en)
JP2001048826A (en) Production of 1-phenyl-1,3-butanedione
JPH09157260A (en) Optically active 4,5-diphenyl-2-imidazolidinone derivative
FR2487338A1 (en) 4:methoxyethyl phenol prodn. from a 4:alkoxyphenyl bromide - and a methoxy aldehyde, nitrile or ester, used as intermediate for the cardiovascular agent metoprolol
JPH02250848A (en) Cyclooctane derivative and use thereof
JP2005225809A (en) Optically-active quaternary ammonium salt compound and asymmetric epoxidation reaction using the compound as catalyst
JPH07133270A (en) Chroman derivative and its production
JPH04316538A (en) Production of optically active 3,5-anti-dihydroxycarboxylic acid ester derivative
JPH05213823A (en) Production of optically active 2-isopropenyl-cyclobutanecarboxylic ester
JPH05306265A (en) Production of alpha-sulfonyloxycarboxylic acid ester derivative

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees